Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome
- PMID: 28376323
- DOI: 10.1053/j.gastro.2016.09.068
Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome
Comment in
-
Reply.Gastroenterology. 2017 May;152(6):1630-1631. doi: 10.1053/j.gastro.2017.03.042. Epub 2017 Apr 3. Gastroenterology. 2017. PMID: 28384458 No abstract available.
Comment on
-
Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.Gastroenterology. 2016 Dec;151(6):1113-1121. doi: 10.1053/j.gastro.2016.08.003. Epub 2016 Aug 13. Gastroenterology. 2016. PMID: 27528177 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
